Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1783 2
1789 1
1797 1
1800 1
1801 1
1802 1
1803 1
1805 1
1807 1
1809 1
1814 1
1818 2
1819 1
1820 2
1822 1
1828 1
1829 3
1830 1
1834 1
1838 1
1840 2
1841 1
1842 2
1843 1
1844 1
1845 6
1846 3
1847 3
1848 1
1850 1
1852 1
1853 4
1854 1
1855 3
1857 5
1858 1
1860 3
1865 1
1867 4
1868 1
1870 3
1871 3
1872 2
1873 4
1874 2
1875 2
1876 2
1877 3
1878 3
1879 3
1880 4
1881 9
1883 5
1884 1
1885 2
1886 1
1888 1
1889 2
1890 6
1892 3
1893 6
1894 9
1895 5
1896 7
1897 8
1898 13
1899 4
1900 8
1901 4
1902 12
1903 7
1904 8
1905 4
1906 5
1907 13
1908 14
1909 4
1910 9
1911 1
1912 5
1913 5
1914 8
1915 8
1916 9
1917 9
1918 4
1919 1
1920 9
1921 11
1922 10
1923 12
1924 15
1925 13
1926 15
1927 13
1928 9
1929 14
1930 10
1931 15
1932 17
1933 9
1934 11
1935 17
1936 14
1937 12
1938 25
1939 19
1940 19
1941 8
1942 14
1943 10
1944 11
1945 114
1946 364
1947 456
1948 541
1949 492
1950 810
1951 779
1952 792
1953 764
1954 832
1955 872
1956 797
1957 829
1958 770
1959 843
1960 878
1961 917
1962 991
1963 1224
1964 1641
1965 1033
1966 854
1967 1211
1968 1269
1969 1474
1970 1410
1971 1647
1972 1596
1973 1697
1974 1964
1975 2580
1976 2664
1977 3046
1978 3067
1979 3434
1980 3535
1981 3824
1982 4083
1983 4393
1984 4985
1985 5359
1986 5330
1987 5626
1988 6239
1989 7208
1990 7629
1991 7501
1992 8564
1993 9756
1994 10137
1995 10801
1996 11693
1997 12867
1998 13805
1999 14791
2000 16863
2001 17181
2002 18448
2003 19832
2004 21901
2005 24289
2006 26236
2007 28439
2008 31169
2009 33213
2010 37360
2011 40847
2012 45010
2013 47201
2014 50487
2015 52983
2016 53157
2017 54085
2018 55945
2019 59340
2020 66950
2021 71694
2022 70591
2023 68503
2024 24349

Text availability

Article attribute

Article type

Publication date

Search Results

1,119,570 results

Results by year

Filters applied: . Clear all
Page 1
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC; Karlan BY, Khan S, Klein C, Kohlmann W; CGC; Kurian AW, Laronga C, Litton JK, Mak JS; LCGC; Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC; Senter-Jamieson L; CGC; Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Daly MB, et al. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001. J Natl Compr Canc Netw. 2021. PMID: 33406487
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancrea …
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily o …
Breast Cancer Epidemiology, Prevention, and Screening.
Winters S, Martin C, Murphy D, Shokar NK. Winters S, et al. Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10. Prog Mol Biol Transl Sci. 2017. PMID: 29096890 Review.
Mutations in the BRCA 1 and BRCA 2 tumor suppressor genes are significantly associated with the development of breast and ovarian cancer by the age of 70. ...Identification of women at risk for BRCA1 and BRCA 2 mutations …
Mutations in the BRCA 1 and BRCA 2 tumor suppressor genes are significantly associated with the development of breas …
Ovarian Cancer Prevention and Screening.
Menon U, Karpinskyj C, Gentry-Maharaj A. Menon U, et al. Obstet Gynecol. 2018 May;131(5):909-927. doi: 10.1097/AOG.0000000000002580. Obstet Gynecol. 2018. PMID: 29630008 Review.
There has been much progress in ovarian cancer screening and prevention in recent years. Improved tools that combine genetic and epidemiologic factors to predict an individual's ovarian cancer risk are set to become available for t …
There has been much progress in ovarian cancer screening and prevention in recent years. Improved tools that combine …
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Grummet J, Henry AM, van der Kwast TH, Lam TB, Lardas M, Liew M, Mason MD, Moris L, Oprea-Lager DE, van der Poel HG, Rouvière O, Schoots IG, Tilki D, Wiegel T, Willemse PM, Cornford P. Mottet N, et al. Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7. Eur Urol. 2021. PMID: 33172724
Risk-adapted screening should be offered to men at increased risk from the age of 45 yr and to breast cancer susceptibility gene (BRCA) mutation carriers, who have been confirmed to be at risk of early and aggressive …
Risk-adapted screening should be offered to men at increased risk from the age of 45 yr and to breast cancer …
Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V. Mahdavi M, et al. J Cell Physiol. 2019 May;234(5):5741-5750. doi: 10.1002/jcp.27464. Epub 2018 Dec 14. J Cell Physiol. 2019. PMID: 30552672 Review.
Germline mutations in BRCA1 and BRCA2 genes are the main genetic and inherited factors for breast and ovarian cancer. ...Therefore, according to the conducted studies, screening of BRCA1 and BRCA2 genes is recommended as an important mark …
Germline mutations in BRCA1 and BRCA2 genes are the main genetic and inherited factors for breast and ovarian …
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, Sur S, Ghosh M, Agarwal A, Sarin R, Ahmed R, Almel S, Chakraborti B, Raina V, DadiReddy PK, Smruti BK, Rajappa S, Dodagoudar C, Aggarwal S, Singhal M, Joshi A, Kumar R, Kumar A, Mishra DK, Arora N, Karaba A, Sankaran S, Katragadda S, Ghosh A, Veeramachaneni V, Hariharan R, Mannan AU. Singh J, et al. Breast Cancer Res Treat. 2018 Jul;170(1):189-196. doi: 10.1007/s10549-018-4726-x. Epub 2018 Feb 22. Breast Cancer Res Treat. 2018. PMID: 29470806
However, the burden attributable to inherited mutations is not well characterized. METHODS: We sequenced 1010 unrelated patients and families from across India with an indication of breast and/or ovarian cancers, using the TruSight Cancer panel which i …
However, the burden attributable to inherited mutations is not well characterized. METHODS: We sequenced 1010 unrelated patients and …
The Importance of Breast Adipose Tissue in Breast Cancer.
Kothari C, Diorio C, Durocher F. Kothari C, et al. Int J Mol Sci. 2020 Aug 11;21(16):5760. doi: 10.3390/ijms21165760. Int J Mol Sci. 2020. PMID: 32796696 Free PMC article. Review.
We will focus on understanding the biology of breast adipose tissue, with an overview on its involvement in the various steps of breast cancer development and progression. The interaction between the breast adipose tissue surrounding cancer cell …
We will focus on understanding the biology of breast adipose tissue, with an overview on its involvement in the various steps of b …
Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Wang YA, Jian JW, Hung CF, Peng HP, Yang CF, Cheng HS, Yang AS. Wang YA, et al. BMC Cancer. 2018 Mar 22;18(1):315. doi: 10.1186/s12885-018-4229-5. BMC Cancer. 2018. PMID: 29566657 Free PMC article.
METHODS: The study cohort included 480 ethnic Chinese individuals in Taiwan with at least one of the six clinical risk factors for hereditary breast cancer: family history of breast or ovarian cancer, young age of onset for breast …
METHODS: The study cohort included 480 ethnic Chinese individuals in Taiwan with at least one of the six clinical risk factors for he …
Diagnosis and Management of Ovarian Cancer.
Doubeni CA, Doubeni AR, Myers AE. Doubeni CA, et al. Am Fam Physician. 2016 Jun 1;93(11):937-44. Am Fam Physician. 2016. PMID: 27281838 Free article.
The strongest risk factors are advancing age and family history of ovarian and breast cancer. ...Despite the low rate of early diagnosis, guidelines recommend against routine screening for ovarian cancer in average- …
The strongest risk factors are advancing age and family history of ovarian and breast cancer. ...Despite the low …
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987. JAMA. 2019. PMID: 31429903
IMPORTANCE: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and peritoneal cancer. ...EVIDENCE REVIEW: The USPSTF rev …
IMPORTANCE: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) are associated wi …
1,119,570 results
You have reached the last available page of results. Please see the User Guide for more information.